Revised: 16 February 2021
COVID-19
Approval status of COVID vaccines applications received by Medsafe
Comirnaty (COVID-19 mRNA vaccine) (Pfizer-BioNTech) 0.5 mg/mL concentrate for injection (TT50-10853)
Approval pathway: rolling abbreviated application
Status: Approved under section 23 of the Medicines Act, with conditions.
Documents:
See also: mRNA Vaccines
Janssen COVID-19 (Ad26.COV2.S), Vaccine suspension 5 x 1010 VP/0.5 mL (TT50-10862)
Approval pathway: rolling abbreviated application
Status: Application received, some data under evaluation, further data to be provided by sponsor.